Drugs / CBP-174
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04811469 | May 2021 → May 2022 | — | Connect Biopharm LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBP-174 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04811469 ↗ |
| Route | Oral | “single oral dose” NCT04811469 ↗ |